title: Suppression subtractive hybridization to identify gene expressions in variant and classic small cell lung cancer cell lines.
abstract: Small Cell Lung Cancer (SCLC), a clinically aggressive cancer, accounts for approximately 25% of primary lung cancers. We carried out suppression subtractive hybridization (SSH), a PCR-based method for cDNA subtraction, between the human classic, NCI-H69 and variant, more aggressive NCI-N417 SCLC cell lines to isolate and characterize variable expression of genes, which may be responsible for differential degree of tumorigenicity of SCLC. Using NCI-N417 as a tester, we obtained 28 differentially expressed cDNA clones from a total of 60 arbitrarily picked clones. Among the 28 cDNA clones, 4 were unknown genes, 2 were fatty acid binding protein (FABP) with specific identification of mRNA for mammary-derived growth inhibitor (MDGI), 1 was human alpha-enolase, 4 were ribosomal proteins, 2 were structural genes, vimentin and moesin (membrane-organizing extension spike protein), and 9 were homologous with murine leukemia viruses, whereas 2 others had enhanced expression in NCI-H69 and A549 cell lines, and 4 were cell surface proteins and murine type C retrovirus. Expression of FABP/MDGI was significantly high in NCI-H417, which may influence mitosis and cell growth as implicated in other tissues, contrary to the conclusion drawn for the role of MDGI in human breast cancer. Higher expression of ribosomal proteins in NCI-N417 compared to NCI-H69 may have a role in differential tumorigenicity and metastatic ability. Further, we obtained 14 differentially expressed cDNA clones by reversing the tester and driver, using NCI-H69 as a tester. Of these 14 differential cDNAs, 5 were unknown genes, 2 were specific for keratins, others had similarities with protease inhibitor, human BAC clone, Alu RNA binding protein, and tumor expression-enhanced gene. Characterization of these differentially expressed cDNA clones will provide useful information in understanding of the genes responsible for differential tumorigenicity of SCLC.
authors.affiliation: Lung Development Research Program, The Pennsylvania State University, Hershey, Pennsylvania 17033, USA.
authors.forename: L
authors.initials: L
authors.lastname: Zhang
authors.forename: R E
authors.initials: RE
authors.lastname: Cilley
authors.forename: M R
authors.initials: MR
authors.lastname: Chinoy
mesh_terms: D001483:Base Sequence; D015152:Blotting, Northern; D018288:Carcinoma, Small Cell / Q000235:genetics*; D002352:Carrier Proteins / Q000235:genetics / Q000502:physiology; D018076:DNA, Complementary / Q000032:analysis; D000074026:Fatty Acid Binding Protein 3; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D015870:Gene Expression; D005982:Glutathione Transferase / Q000235:genetics; D006801:Humans; D007633:Keratins / Q000235:genetics; D008175:Lung Neoplasms / Q000235:genetics*; D008969:Molecular Sequence Data; D018996:Myelin P2 Protein / Q000235:genetics; D009363:Neoplasm Proteins; D012269:Ribosomal Proteins / Q000235:genetics / Q000502:physiology; D014407:Tumor Cells, Cultured; D025521:Tumor Suppressor Proteins; D014746:Vimentin / Q000235:genetics
chemical_list: D002352:Carrier Proteins; D018076:DNA, Complementary; C493408:FABP3 protein, human; C107608:FABP7 protein, human; C493409:Fabp3 protein, mouse; D000074026:Fatty Acid Binding Protein 3; D000071438:Fatty Acid-Binding Protein 7; D050556:Fatty Acid-Binding Proteins; D018996:Myelin P2 Protein; D009363:Neoplasm Proteins; D012269:Ribosomal Proteins; D025521:Tumor Suppressor Proteins; D014746:Vimentin; D007633:Keratins; D005982:Glutathione Transferase